LACTULOSE
LAXATIVES · HYPERAMMONEMIA ·+2
TRIFLUENT PHARM
Drug class
Ammonia Absorption Inhibitors for Hepatic Encephalopathy
Although not a formal standalone class in official FDA or ATC classification systems, "ammonia absorption inhibitors for hepatic encephalopathy" describes a functional category of gastrointestinal agents, primarily nonabsorbable disaccharides such as lactulose and lactitol. Read more about Ammonia Absorption Inhibitors for Hepatic Encephalopathy
23 drugs in this class 21 manufacturers
Drugs in Ammonia Absorption Inhibitors for Hepatic Encephalopathy
Filter & compare in the drug finder →
Opens the drug finder with Ammonia Absorption Inhibitors for Hepatic Encephalopathy preselected. Add indication or manufacturer filters there.
Although not a formal standalone class in official FDA or ATC classification systems, "ammonia absorption inhibitors for hepatic encephalopathy" describes a functional category of gastrointestinal agents, primarily nonabsorbable disaccharides such as lactulose and lactitol.
These agents are metabolized by colonic bacteria into organic acids that acidify the intestinal lumen, trapping diffuse ammonia as nonabsorbable ammonium ions and accelerating fecal transit to prevent systemic absorption.
Their therapeutic role is to reduce circulating neurotoxin levels, serving as a first-line intervention for the prevention and acute management of hepatic encephalopathy secondary to liver cirrhosis or severe hepatic insufficiency.
-
uw.edu
Although not a formal standalone class in official FDA or ATC classification systems, "ammonia absorption inhibitors for hepatic encephalopathy" describes a functional category of gastrointestinal agents, primarily nonabsorbable disaccharides such as lactulose and lactitol These agents are metabolized by colonic bacteria into organic acids that acidify the intestinal lumen, trapping diffuse ammonia as nonabsorbable ammonium ions and accelerating fecal transit to prevent systemic absorption Their...
-
ajmc.com
These agents are metabolized by colonic bacteria into organic acids that acidify the intestinal lumen, trapping diffuse ammonia as nonabsorbable ammonium ions and accelerating fecal transit to prevent systemic absorption
-
nih.gov
Their therapeutic role is to reduce circulating neurotoxin levels, serving as a first-line intervention for the prevention and acute management of hepatic encephalopathy secondary to liver cirrhosis or severe hepatic insufficiency
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.